CD47 expression and CD163+ macrophages correlated with prognosis of pancreatic neuroendocrine tumor
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
CD47 expression and CD163+ macrophages correlated with prognosis of pancreatic neuroendocrine tumor
Authors
Keywords
-
Journal
BMC CANCER
Volume 21, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2021-03-25
DOI
10.1186/s12885-021-08045-7
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Association between CD47 expression, clinical characteristics and prognosis in patients with advanced non‐small cell lung cancer
- (2020) Oscar Arrieta et al. Cancer Medicine
- Advances in Anti-Tumor Treatments Targeting the CD47/SIRPα Axis
- (2020) Wenting Zhang et al. Frontiers in Immunology
- Biomarkers for Pancreatic Neuroendocrine Neoplasms (PanNENs) Management—An Updated Review
- (2020) Martine Bocchini et al. Frontiers in Oncology
- Role of CD47 in Hematological Malignancies
- (2020) Entsar Eladl et al. Journal of Hematology & Oncology
- CD47 (Cluster of differentiation 47): an anti-phagocytic receptor with a multitude of signaling functions
- (2020) Pascal Leclair et al. Animal Cells and Systems
- The diagnostic utility of EZH2 H-score and Ki-67 index in non-invasive breast apocrine lesions
- (2020) Theodore Vougiouklakis et al. PATHOLOGY RESEARCH AND PRACTICE
- Role of Tumor Associated Macrophages in the Clinical Course of Pancreatic Neuroendocrine Tumors (PanNETs)
- (2019) Lei Cai et al. CLINICAL CANCER RESEARCH
- The Tumor Microenvironment in Neuroendocrine Tumors: Biology and Therapeutic Implications
- (2019) Mauro Cives et al. NEUROENDOCRINOLOGY
- Study on Diagnostic Values of Astrocyte Elevated Gene 1 (AEG-1) and Glypican 3 (GPC-3) in Hepatocellular Carcinoma
- (2019) Wenqing Cao et al. AMERICAN JOURNAL OF CLINICAL PATHOLOGY
- Checkpoint CD47 Function On Tumor Metastasis And Immune Therapy
- (2019) Shu Lian et al. OncoTargets and Therapy
- Blocking CD47 efficiently potentiated therapeutic effects of anti-angiogenic therapy in non-small cell lung cancer
- (2019) Xuyao Zhang et al. Journal for ImmunoTherapy of Cancer
- CD163 is required for protumoral activation of macrophages in human and murine sarcoma
- (2018) Daisuke Shiraishi et al. CANCER RESEARCH
- Redundancy and robustness versus division of labour and specialization in innate immunity
- (2018) Alberto Mantovani SEMINARS IN IMMUNOLOGY
- SIRPα–CD47 Immune Checkpoint Blockade in Anticancer Therapy
- (2018) André Veillette et al. TRENDS IN IMMUNOLOGY
- Expression and significance of CD47, PD1 and PDL1 in T-cell acute lymphoblastic lymphoma/leukemia
- (2018) Kun Yang et al. PATHOLOGY RESEARCH AND PRACTICE
- The CD47-SIRPα signaling axis as an innate immune checkpoint in cancer
- (2017) Hanke L. Matlung et al. IMMUNOLOGICAL REVIEWS
- Tumour-associated macrophages as treatment targets in oncology
- (2017) Alberto Mantovani et al. Nature Reviews Clinical Oncology
- Significance of CD47 expression in gastric cancer
- (2017) Tomoya Sudo et al. Oncology Letters
- Targeting CD47: the achievements and concerns of current studies on cancer immunotherapy
- (2017) Yuting Huang et al. Journal of Thoracic Disease
- Anti-CD47 Antibody As a Targeted Therapeutic Agent for Human Lung Cancer and Cancer Stem Cells
- (2017) Liang Liu et al. Frontiers in Immunology
- Trends in the Incidence, Prevalence, and Survival Outcomes in Patients With Neuroendocrine Tumors in the United States
- (2017) Arvind Dasari et al. JAMA Oncology
- TTI-621 (SIRPαFc), a CD47-blocking cancer immunotherapeutic, triggers phagocytosis of lymphoma cells by multiple polarized macrophage subsets
- (2017) Gloria H. Y. Lin et al. PLoS One
- Targeting the tumor microenvironment: removing obstruction to anticancer immune responses and immunotherapy
- (2016) J. M. Pitt et al. ANNALS OF ONCOLOGY
- Identification of tumorigenic cells and therapeutic targets in pancreatic neuroendocrine tumors
- (2016) Geoffrey Wayne Krampitz et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Thrombospondin-1 signaling through CD47 inhibits cell cycle progression and induces senescence in endothelial cells
- (2016) Qi Gao et al. Cell Death & Disease
- CD47 deficiency in tumor stroma promotes tumor progression by enhancing angiogenesis
- (2016) Lu Gao et al. Oncotarget
- The concept of immune surveillance against tumors: The first theories
- (2016) Domenico Ribatti Oncotarget
- Expression of mouse CD47 on human cancer cells profoundly increases tumor metastasis in murine models
- (2015) Armando Rivera et al. BMC CANCER
- Macrophage subtype predicts lymph node metastasis in oesophageal adenocarcinoma and promotes cancer cell invasion in vitro
- (2015) Wenqing Cao et al. BRITISH JOURNAL OF CANCER
- Immune Checkpoint Targeting in Cancer Therapy: Toward Combination Strategies with Curative Potential
- (2015) Padmanee Sharma et al. CELL
- CD47 is an adverse prognostic factor and a therapeutic target in gastric cancer
- (2015) Kazumichi Yoshida et al. Cancer Medicine
- Clinical significance of macrophage heterogeneity in human malignant tumors
- (2013) Yoshihiro Komohara et al. CANCER SCIENCE
- Pancreatic neuroendocrine tumors
- (2013) Geoffrey W. Krampitz et al. CURRENT PROBLEMS IN SURGERY
- Anti-CD47 antibody-mediated phagocytosis of cancer by macrophages primes an effective antitumor T-cell response
- (2013) D. Tseng et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- CD47 update: a multifaceted actor in the tumour microenvironment of potential therapeutic interest
- (2012) E Sick et al. BRITISH JOURNAL OF PHARMACOLOGY
- TNM Staging of Neoplasms of the Endocrine Pancreas: Results From a Large International Cohort Study
- (2012) G. Rindi et al. JNCI-Journal of the National Cancer Institute
- Emerging roles of the tumor-associated stroma in promoting tumor metastasis
- (2012) Yoshiya Horimoto et al. Cell Adhesion & Migration
- CD47 applies the brakes to angiogenesis via vascular endothelial growth factor receptor-2
- (2011) Sukhbir Kaur et al. CELL CYCLE
- M2 Macrophages Induced by Prostaglandin E2 and IL-6 from Cervical Carcinoma Are Switched to Activated M1 Macrophages by CD4+ Th1 Cells
- (2011) M. Heusinkveld et al. JOURNAL OF IMMUNOLOGY
- Anti-CD47 Antibody Synergizes with Rituximab to Promote Phagocytosis and Eradicate Non-Hodgkin Lymphoma
- (2010) Mark P. Chao et al. CELL
- Macrophage Diversity Enhances Tumor Progression and Metastasis
- (2010) Bin-Zhi Qian et al. CELL
- CD47 Is an Adverse Prognostic Factor and Therapeutic Antibody Target on Human Acute Myeloid Leukemia Stem Cells
- (2009) Ravindra Majeti et al. CELL
- Non-functional Neuroendocrine Carcinoma of the Pancreas: Incidence, Tumor Biology, and Outcomes in 2,158 Patients
- (2009) Jan Franko et al. JOURNAL OF GASTROINTESTINAL SURGERY
- Expression of Src Homology 2 Domain-Containing Protein Tyrosine Phosphatase Substrate-1 in Pancreatic β-Cells and Its Role in Promotion of Insulin Secretion and Protection against Diabetes
- (2008) Masaki Kobayashi et al. ENDOCRINOLOGY
- Gastroenteropancreatic neuroendocrine tumours
- (2008) Irvin M Modlin et al. LANCET ONCOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now